Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
When facing a diagnosis of stomach cancer, understanding the Treatment Details is essential for making informed decisions about care. At Liv Hospital, we provide a clear roadmap that guides international patients through every step—from initial assessment to post‑treatment follow‑up. Each year, thousands of patients worldwide seek advanced oncology services, and recent statistics show that early‑stage detection combined with personalized therapy can improve five‑year survival rates by up to 30 %.
This page presents a comprehensive overview of the therapeutic options available for stomach cancer, explains how our multidisciplinary team tailors each plan, and outlines the support services that make the journey smoother for patients traveling from abroad. Whether you are exploring surgical possibilities, systemic therapies, or cutting‑edge clinical trials, the information below will help you understand what to expect and how to prepare.
Our goal is to empower you with transparent, evidence‑based Treatment Details so you can collaborate confidently with your oncologists and make choices that align with your health goals and personal circumstances.
The stage of stomach cancer at diagnosis is the primary driver of the Treatment Details we recommend. Staging follows the TNM system, which evaluates tumor size (T), lymph node involvement (N), and metastasis (M). Early‑stage disease (Stage I‑II) often allows for curative intent surgery, while advanced stages (Stage III‑IV) may require a combination of systemic therapies before surgery can be considered.
Accurate staging is achieved through a series of diagnostic procedures, including endoscopic ultrasound, CT/MRI scans, and laparoscopic assessment. The results guide the multidisciplinary team in selecting the most appropriate therapeutic pathway.
Understanding where you fall within this framework clarifies the Treatment Details that will be most effective, helping you anticipate the sequence of interventions and the associated recovery timelines.
Surgery remains the cornerstone of curative treatment for localized stomach cancer. The specific procedure depends on tumor location, size, and stage, and is performed by experienced gastrointestinal surgeons using minimally invasive or open techniques.
For patients with advanced disease where resection is not feasible, palliative surgery can alleviate symptoms such as obstruction or bleeding. Options include gastro‑jejunostomy (bypass) and endoscopic stenting.
Our surgical team follows Enhanced Recovery After Surgery (ERAS) protocols, which incorporate pre‑operative nutrition optimization, minimally invasive techniques, and early mobilization. These protocols have been shown to shorten hospital stays by up to 30 % without compromising safety.
Systemic treatments address cancer cells that have spread beyond the primary tumor. At Liv Hospital, we tailor chemotherapy regimens, integrate targeted agents, and consider immunotherapy based on molecular profiling.
These combinations are typically administered in cycles every two to three weeks, with dose adjustments guided by blood counts and organ function.
Testing for HER2 overexpression and other biomarkers is performed on biopsy samples, ensuring that patients who can benefit from targeted agents receive them early in the treatment course.
Clinical trial participation is encouraged when appropriate, offering access to emerging therapies that may further improve outcomes.
Radiation therapy is employed as an adjunct to surgery or systemic therapy, particularly for locally advanced tumors where margins are close or positive. Advanced techniques such as Intensity‑Modulated Radiation Therapy (IMRT) and Image‑Guided Radiation Therapy (IGRT) allow precise targeting while sparing surrounding healthy tissue.
Our radiation oncology team collaborates closely with surgeons and medical oncologists to synchronize treatment timing, minimizing interruptions and maximizing therapeutic synergy.
Effective cancer care extends beyond tumor‑directed treatments. Liv Hospital offers a comprehensive supportive care program that addresses nutrition, pain management, psychological well‑being, and physical rehabilitation.
International patients benefit from a dedicated care coordinator who assists with travel logistics, interpreter services, and accommodation arrangements, ensuring a seamless experience throughout the treatment journey.
Liv Hospital combines JCI accreditation, a multidisciplinary oncology team, and state‑of‑the‑art facilities to deliver world‑class stomach cancer care. Our international patient program handles every detail—from visa assistance to post‑treatment follow‑up—so you can focus on recovery. With access to robotic surgery, targeted therapies, and clinical trials, you receive cutting‑edge treatment tailored to your unique clinical profile.
Ready to discuss your personalized stomach cancer treatment plan? Contact Liv Hospital today to schedule a confidential consultation and take the first step toward comprehensive, compassionate care.
Send us all your questions or requests, and our expert team will assist you.
The choice of treatment depends on the cancer stage and the patient’s overall health. Early‑stage disease is often managed with curative surgery, sometimes combined with peri‑operative chemotherapy. Advanced stages may require neoadjuvant chemotherapy to shrink the tumor before surgery, followed by adjuvant therapy. Targeted agents like trastuzumab are used for HER2‑positive tumors, while immunotherapy drugs such as pembrolizumab are offered for PD‑L1‑positive disease. Radiation therapy is added when margins are close or for palliation. Throughout, supportive services address nutrition, pain, psychological well‑being, and rehabilitation.
Stomach cancer is staged using the TNM system, which evaluates tumor depth (T), nodal involvement (N), and distant metastasis (M). Stage I‑II tumors are usually resectable, allowing curative surgery with or without peri‑operative chemotherapy. Stage III disease often requires neoadjuvant chemotherapy to downstage the tumor before surgery, followed by adjuvant therapy. Stage IV disease is considered metastatic; treatment focuses on systemic therapy, targeted agents, and palliative measures rather than curative surgery. Accurate staging through endoscopic ultrasound, CT/MRI, and laparoscopy guides the multidisciplinary team in selecting the optimal sequence of interventions.
The surgical approach depends on tumor location, size, and stage. For distal tumors, a subtotal (distal) gastrectomy removes the lower stomach portion, while proximal or extensive tumors may require a total gastrectomy. Systematic lymphadenectomy is performed to remove regional nodes and reduce recurrence risk. Advanced minimally invasive techniques, such as robotic‑assisted gastrectomy, provide greater precision, less blood loss, and faster recovery. When curative resection is not possible, palliative procedures like gastro‑jejunostomy or endoscopic stenting relieve obstruction or bleeding. All surgeries follow Enhanced Recovery After Surgery (ERAS) protocols to improve outcomes.
FOLFOX combines 5‑fluorouracil, leucovorin, and oxaliplatin and is widely used in both neoadjuvant and adjuvant settings. ECX (epirubicin, cisplatin, capecitabine) offers a more intensive option for fit patients. The SOX regimen pairs S‑1 (an oral fluoropyrimidine) with oxaliplatin and is popular in Asian protocols but also used internationally. Treatment cycles are typically repeated every two to three weeks, with dose adjustments based on blood counts, renal and hepatic function, and patient tolerance. Response is monitored with imaging and tumor markers, and therapy may be switched if disease progresses.
Neoadjuvant radiation (45‑50 Gy in 25 fractions) is given before surgery to shrink the tumor and improve resectability. Post‑operative (adjuvant) radiation (typically 45 Gy) targets the tumor bed and regional lymph nodes to eradicate microscopic disease. For patients with unresectable or metastatic disease, palliative radiation (e.g., 20 Gy in 5 fractions) helps control bleeding, pain, or obstruction. Advanced techniques such as Intensity‑Modulated Radiation Therapy (IMRT) and Image‑Guided Radiation Therapy (IGRT) allow precise dose delivery while sparing surrounding organs, reducing side effects.
BlogCancerFeb 18, 2026Medical imaging tests, like CT scans, use contrast agents to make internal structures clearer. These substa...
BlogCancerNov 03, 2025Bloated stomach is a common symptom of stomach cancer, often indicating progression or metastasis. Our expe...
BlogCancerNov 03, 2025Stomach cancer is one of the deadliest forms of cancer, with only 7% of those with metastatic disease survi...
BlogCancerSep 30, 2025Can stomach cancer cause itchy skin? Many people are unaware that stomach cancer can present in unusual way...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24
